Published in Medical Letter on the CDC and FDA, June 10th, 1996
In October 1994, the Second National Conference on the Serologic Diagnosis of Lyme Disease (Centers for Disease Control and Prevention/Association of State and Public Health Laboratory Directors [CDC/ASTPHLD]) recommended new criteria for serological testing and interpretation of Western blots (immunoblots) in the diagnosis of Lyme disease (CDC, MMWR, 1995;44:590-591).
Eileen Hilton and colleagues, Long Island Jewish Medical Center, New Hyde Park, New York, reviewed the recommendations and reported on their evaluation of how the new criteria...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA